The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Systemic Inflammatory Response Syndrome After Acute Myocardial Infarction Complicated by Cardiogenic Shock
Abstract
BACKGROUND: The role of inflammation in patients with coronary artery disease is emerging. We sought to assess the profile and outcomes of patients with a clinical syndrome of severe systemic inflammation that led to a diagnosis of suspected sepsis in the setting of acute myocardial infarction complicated by cardiogenic shock (CS). METHODS: Patients enrolled in the randomized SHOCK (SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK) trial (n = 302) were divided into those with clinical signs of severe systemic inflammation (eg, fever [94%] or leukocytosis [72%]) that led to a diagnosis of suspected sepsis (n = 54 [18%]) and those without suspected sepsis (controls; n = 243 [80%]). The patients with suspected sepsis were then further subdivided into those who were considered to be potentially infectious (positive culture result ["culture-positive"]; n = 40) and those who were not (negative culture result ["culture-negative"]; n = 14). RESULTS: Severe systemic inflammation was diagnosed 4 and 2 days after the onset of CS in culture-positive and culture-negative patients, respectively. Patients who developed systemic inflammation tended to be younger (P = .05) and to have lower systemic vascular resistance (SVR) near the onset of CS (P = .006). Many culture-positive patients (40%) had undergone coronary artery bypass graft surgery. However, the lower the initial SVR, the higher the risk of developing culture-positive systemic inflammation (P = .01), even after controlling for age and coronary artery bypass graft surgery. A time-dependent model, adjusted for age, showed that culture-positive patients were at significantly higher risk for death than were controls (hazard ratio, 2.22; 95% confidence interval, 1.32-3.76; P = .008). CONCLUSIONS: Almost one fifth of patients with acute myocardial infarction complicated by CS showed clinical signs of severe systemic inflammation, and those who were culture-positive for sepsis had twice the risk of death. The observation of lower SVR at the onset of shock in patients who subsequently had culture-positive systemic inflammation suggests that inappropriate vasodilation may play an important role in the pathogenesis and persistence of shock and in the risk of infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Hochman, J. S., Sleeper, L. A., Webb, J. G., Sanborn, T. A., White, H. D., Talley, J. D., Buller, C. E., Jacobs, A. K., Slater, J. N., Col, J., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908263410901 · Cited by 3,131
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,357
Current Concepts of the Pathogenesis of the Acute Coronary Syndromes
Libby, P. (2001) · Circulation · doi:10.1161/01.cir.104.3.365 · Cited by 1,558
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S. D., Gallimore, J. R., & Group, M. B. P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,500
Widespread Coronary Inflammation in Unstable Angina
Buffon, A., Biasucci, L. M., Liuzzo, G., D'Onofrio, G., Crea, F., & Maseri, A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012295 · Cited by 922
One-Year Survival Following Early Revascularization for Cardiogenic Shock
Hochman, J. S. (2001) · JAMA · doi:10.1001/jama.285.2.190 · Cited by 679
Cardiogenic Shock Complicating Acute Myocardial Infarction: Expanding the Paradigm
Hochman, J. S. (2003) · Circulation · doi:10.1161/01.cir.0000075927.67673.f2 · Cited by 641
Cardiac Release of Cytokines and Inflammatory Responses in Acute Myocardial Infarction
Neumann, F.-J., Ott, I., Gawaz, M., Richardt, G., Holzapfel, H., Jochum, M., & Schömig, A. (1995) · Circulation · doi:10.1161/01.cir.92.4.748 · Cited by 501
Hall, R. I., Smith, M. S., & Rocker, G. (1997) · Anesthesia & Analgesia · doi:10.1097/00000539-199710000-00011 · Cited by 407
Granger, C. B., Mahaffey, K. W., Weaver, W. D., Theroux, P., Hochman, J. S., Filloon, T. G., Rollins, S., Todaro, T. G., Nicolau, J. C., Ruzyllo, W., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087447.12918.85 · Cited by 323
Enhanced Inflammatory Response to Coronary Angioplasty in Patients With Severe Unstable Angina
Liuzzo, G., Buffon, A., Biasucci, L. M., Gallimore, J. R., Caligiuri, G., Vitelli, A., Altamura, S., Ciliberto, G., Rebuzzi, A. G., Crea, F., et al. (1998) · Circulation · doi:10.1161/01.cir.98.22.2370 · Cited by 307
Menon, V., Slater, J. N., White, H. D., Sleeper, L. A., Cocke, T., & Hochman, J. S. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00310-7 · Cited by 240
Hochman, J. S., Sleeper, L. A., Godfrey, E., McKinlay, S. M., Sanborn, T. A., Col, J. J., & LeJemtel, T. H. (1999) · American Heart Journal · doi:10.1053/hj.1999.v137.95352 · Cited by 202
Acute T-Cell Activation Is Detectable in Unstable Angina
Neri Serneri, G. G., Prisco, D., Martini, F., Gori, A., Brunelli, T., Poggesi, L., Rostagno, C., Gensini, G. F., & Abbate, R. (1997) · Circulation · doi:10.1161/01.cir.95.7.1806 · Cited by 186
Cotter, G. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00193-3 · Cited by 162
L-NMMA (a Nitric Oxide Synthase Inhibitor) is Effective in the Treatment of Cardiogenic Shock
Cotter, G., Kaluski, E., Blatt, A., Milovanov, O., Moshkovitz, Y., Zaidenstein, R., Salah, A., Alon, D., Michovitz, Y., Metzger, M. W., et al. (2000) · Circulation · doi:10.1161/01.cir.101.12.1358 · Cited by 141
Geppert, A., Steiner, A., Zorn, G., Delle‐Karth, G., Koreny, M., Haumer, M., Siostrzonek, P., Huber, K., & Heinz, G. (2002) · Critical Care Medicine · doi:10.1097/00003246-200209000-00007 · Cited by 129
Hemodynamic Studies in Cardiogenic Shock: Treatment with Isoproterenol and Metaraminol
Smith, H.-J., Oriol, A., Morch, J. E., & McGregor, M. (1967) · Circulation · doi:10.1161/01.cir.35.6.1084 · Cited by 90
Pathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Cited by
van Diepen, S., Katz, J. N., Albert, N. M., Henry, T. D., Jacobs, A. K., Kapur, N. K., Kilic, A., Menon, V., Ohman, E. M., Sweitzer, N. K., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000525 · Cited by 1,869
Baran, D. A., Grines, C. L., Bailey, S., Burkhoff, D., Hall, S. A., Henry, T. D., Hollenberg, S. M., Kapur, N. K., O'Neill, W., Ornato, J. P., et al. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28329 · Cited by 1,017
Cardiogenic Shock: Current Concepts and Improving Outcomes
Reynolds, H. R., & Hochman, J. S. (2008) · Circulation · doi:10.1161/circulationaha.106.613596 · Cited by 820
Chioncel, O., Parissis, J., Mebazaa, A., Thiele, H., Desch, S., Bauersachs, J., Harjola, V.-P., Antohi, E.-L., Arrigo, M., Ben Gal, T., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1922 · Cited by 493
Metadata
- Authors
- Kohsaka, S.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2005-07-25
- Volume
- 165
- Issue
- 14
- Pages
- 1643
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2161190675
- Cited by
- 343
- References
- 19
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.